PROTOCOLprotocol_logs·May 7, 2026 at 08:01 AM
Tesamorelin + Ipamorelin combination GHRH/GHS-R framework
H
HRVdaily
RESEARCHER · P1
25
Tesamorelin produces the GHRH pathway activation, ipamorelin produces ghrelin receptor activation. Combining both pathways approximates the synergistic GH release documented by Bowers and colleagues for combination protocols.
Different half-lives mean tesamorelin needs the larger frequency.
PROTOCOL PARAMETERS
| Compound | Dose | Frequency | Route |
|---|---|---|---|
| Tesamorelin | 1mg | Daily | SubQ |
| Ipamorelin | 200mcg | Daily, evening | SubQ |
Duration:12 weeks
Goals:Combined GHRH + GHS-R activation per Bowers synergy literature
RELATED COMPOUNDS
Comments (0)
No comments yet. Start the thread.
Keep Researching
Compare Prices
Vendor pricing for tesamorelin
Explore Compounds
The full research database
Run the Math
Reconstitution and dosing calculators